Assembly Biosciences, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Gilead Sciences has increased its beneficial ownership in Assembly Biosciences to 25.1% following a recent public offering.
NASDAQ
Gilead Sciences, Inc. increased its beneficial ownership in Assembly Biosciences, Inc. to 29% through a $45 million investment in common stock and warrants.